Eon Case Study
April 13, 2021
Even though pancreatic cancer makes up only 3.2% of all new cancer diagnoses each year in the U.S., it is the third leading cause of cancer death with a 5-year survival rate of just 9%. Most incidental pancreatic cysts are benign, but malignant cysts offer an opportunity for early intervention when pancreatic cancer is most treatable. Our latest white paper explains incidental pancreatic cyst identification and management, and why early tracking is so important.